{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:38:32Z","timestamp":1791398312105,"version":"4.3.3"},"reference-count":188,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T00:00:00Z","timestamp":1543017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126897"],"award-info":[{"award-number":["R01HL126897"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX000101"],"award-info":[{"award-number":["I01CX000101"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX002499"],"award-info":[{"award-number":["I01BX002499"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Interstitial lung disease (ILD) and pulmonary fibrosis comprise a wide array of inflammatory and fibrotic lung diseases which are often confusing to general medicine and pulmonary physicians alike. In addition to the myriad of clinical and radiologic nomenclature used in ILD, histopathologic descriptors may be particularly confusing, and are often extrapolated to radiologic imaging patterns which may further add to the confusion. We propose that rather than focusing on precise histologic findings, focus should be on identifying an accurate etiology of ILD through a comprehensive and detailed medical history. Histopathologic patterns from lung biopsy should not be dismissed, but are often nonspecific, and overall treatment strategy and prognosis are likely to be determined more by the specific etiology of ILD rather than any particular histologic pattern. In this review, we outline a practical approach to common ILDs, highlight important aspects in obtaining an exposure history, clarify terminology and nomenclature, and discuss six common subgroups of ILD likely to be encountered by general medicine physicians in the inpatient or outpatient setting: Smoking-related, hypersensitivity pneumonitis, connective tissue disease-related, occupation-related, medication-induced, and idiopathic pulmonary fibrosis. Accurate diagnosis of these forms of ILD does require supplementing the medical history with results of the physical examination, autoimmune serologic testing, and chest radiographic imaging, but the importance of a comprehensive environmental, avocational, occupational, and medication-use history cannot be overstated and is likely the single most important factor responsible for achieving the best possible outcomes for patients.<\/jats:p>","DOI":"10.3390\/jcm7120476","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T03:24:27Z","timestamp":1543202667000},"page":"476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-627X","authenticated-orcid":false,"given":"Or","family":"Kalchiem-Dekel","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Galvin","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen P.","family":"Burke","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei P.","family":"Atamas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"},{"name":"Baltimore Veterans Affairs Medical Center, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevins W.","family":"Todd","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA"},{"name":"Baltimore Veterans Affairs Medical Center, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,24]]},"reference":[{"key":"ref_1","unstructured":"American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002). This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med., 165, 277\u2013304."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/thx.2008.101691","article-title":"Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1164\/rccm.200903-0349ED","article-title":"The art and science of diagnosing interstitial lung diseases","volume":"179","author":"Kinder","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jcp.2008.059782","article-title":"My approach to interstitial lung disease using clinical, radiological and histopathological patterns","volume":"62","author":"Leslie","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200602-022TK","article-title":"Pulmonary function testing in idiopathic interstitial pneumonias","volume":"3","author":"Martinez","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(16)30033-9","article-title":"Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: A case-cohort study","volume":"4","author":"Walsh","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","article-title":"Idiopathic interstitial pneumonia: What is the effect of a multidisciplinary approach to diagnosis?","volume":"170","author":"Flaherty","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1513\/pats.200602-019TK","article-title":"Histologic spectrum of idiopathic interstitial pneumonias","volume":"3","author":"Visscher","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-5-11","article-title":"Molecular and cellular mechanisms of pulmonary fibrosis","volume":"5","author":"Todd","year":"2012","journal-title":"Fibrogenesis Tissue Repair."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09059180.00003214","article-title":"Cellular interactions in the pathogenesis of interstitial lung diseases","volume":"24","author":"Bagnato","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: Therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1378\/chest.94.6.1309","article-title":"Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia","volume":"94","author":"Myers","year":"1988","journal-title":"Chest."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/17476348.2015.1067609","article-title":"Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis","volume":"9","author":"Todd","year":"2015","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1165\/rcmb.2014-0078OC","article-title":"Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis","volume":"52","author":"Lutz","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22103","DOI":"10.1074\/jbc.M110.121467","article-title":"Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress","volume":"285","author":"Maitra","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.200906-0953OC","article-title":"Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort","volume":"182","author":"Barlo","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","unstructured":"ACCP Interstitial and Diffuse Lung Disease Patient Questionnaire [Internet] (2018, September 12). American College of Chest Physicians Website. Available online: http:\/\/www.chestnet.org\/sitecore modules\/web\/~\/media\/chesnetorg\/Foundation\/Documents\/Lung Disease Questionaire.ashx."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e3978","DOI":"10.1097\/MD.0000000000003978","article-title":"Nontuberculous mycobacterial pulmonary disease mimicking lung cancer: Clinicoradiologic features and diagnostic implications","volume":"95","author":"Hong","year":"2016","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2214\/ajr.181.4.1811059","article-title":"Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS","volume":"181","author":"Franquet","year":"2003","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"W555","DOI":"10.2214\/AJR.11.7329","article-title":"Pneumocystis jiroveci pneumonia: High-resolution CT findings in patients with and without HIV infection","volume":"198","author":"Kanne","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.201702-0400PP","article-title":"A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective","volume":"196","author":"Ryerson","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00000478-199402000-00003","article-title":"Nonspecific interstitial pneumonia\/fibrosis. Histologic features and clinical significance","volume":"18","author":"Katzenstein","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1164\/rccm.200611-1685OC","article-title":"Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society project","volume":"177","author":"Travis","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.rmed.2015.09.015","article-title":"Organizing pneumonia\/non-specific interstitial pneumonia overlap is associated with unfavorable lung disease progression","volume":"109","author":"Todd","year":"2015","journal-title":"Respir. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/thorax.55.4.318","article-title":"Organising pneumonia","volume":"55","author":"Cordier","year":"2000","journal-title":"Thorax"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1164\/ajrccm.164.9.2103074","article-title":"Histopathologic variability in usual and nonspecific interstitial pneumonias","volume":"164","author":"Flaherty","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: Idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5858\/2007-131-407-TBIITP","article-title":"Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease","volume":"131","author":"Leslie","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.01.17201750","article-title":"High short-term mortality following lung biopsy for usual interstitial pneumonia","volume":"17","author":"Utz","year":"2001","journal-title":"Eur. Respir. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1183\/13993003.01633-2016","article-title":"Lung biopsy in interstitial lung disease: Balancing the risk of surgery and diagnostic uncertainty","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ro.2014.05.001","article-title":"The idiopathic interstitial pneumonias: Histology and imaging","volume":"50","author":"Strollo","year":"2015","journal-title":"Semin. Roentgenol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2214\/AJR.05.1826","article-title":"Hypersensitivity pneumonitis: Spectrum of high-resolution CT and pathologic findings","volume":"188","author":"Silva","year":"2007","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.prp.2014.08.013","article-title":"A comparative study of honeycombing on high resolution computed tomography with histologic lung remodeling in explants with usual interstitial pneumonia","volume":"211","author":"Staats","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.200611-1696OC","article-title":"Computed tomography findings in pathological usual interstitial pneumonia: Relationship to survival","volume":"177","author":"Sumikawa","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00330-012-2427-0","article-title":"Chronic hypersensitivity pneumonitis: High resolution computed tomography patterns and pulmonary function indices as prognostic determinants","volume":"22","author":"Walsh","year":"2012","journal-title":"Eur. Radiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","article-title":"Connective tissue disease related fibrotic lung disease: High resolution computed tomographic and pulmonary function indices as prognostic determinants","volume":"69","author":"Walsh","year":"2014","journal-title":"Thorax"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1183\/09031936.00166813","article-title":"Smoking-related idiopathic interstitial pneumonia","volume":"44","author":"Flaherty","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1148\/rg.285075223","article-title":"Smoking-related interstitial lung disease: Radiologic-clinical-pathologic correlation","volume":"28","author":"Attili","year":"2008","journal-title":"Radiographics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.rcl.2016.05.010","article-title":"Clinical-Radiologic-Pathologic Correlation of Smoking-Related Diffuse Parenchymal Lung Disease","volume":"54","author":"Kligerman","year":"2016","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_46","unstructured":"Selman, M., Martinez, F.J., and Pardo, A. (2018). Why an Aging Smoker Lung Develops IPF and Not COPD?. Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trsl.2014.03.011","article-title":"Epigenetics of idiopathic pulmonary fibrosis","volume":"165","author":"Yang","year":"2015","journal-title":"Transl Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/16000617.0050-2015","article-title":"Smoking and interstitial lung diseases","volume":"24","author":"Margaritopoulos","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1378\/chest.127.1.178","article-title":"Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease","volume":"127","author":"Ryu","year":"2005","journal-title":"Chest"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1056\/NEJM197410102911503","article-title":"Pathologic changes in the peripheral airways of young cigarette smokers","volume":"291","author":"Niewoehner","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1183\/09059180.00005812","article-title":"Desquamative interstitial pneumonia: An analytic review with an emphasis on aetiology","volume":"22","author":"Godbert","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9343(65)90206-8","article-title":"Desquamative interstitial pneumonia","volume":"39","author":"Liebow","year":"1965","journal-title":"Am. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJM200006293422607","article-title":"Pulmonary Langerhans\u2019-cell histiocytosis","volume":"342","author":"Vassallo","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.humpath.2009.09.003","article-title":"Clinically occult interstitial fibrosis in smokers: Classification and significance of a surprisingly common finding in lobectomy specimens","volume":"41","author":"Katzenstein","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2559.2008.03183.x","article-title":"Smoking-related changes in the background lung of specimens resected for lung cancer: A semiquantitative study with correlation to postoperative course","volume":"53","author":"Kawabata","year":"2008","journal-title":"Histopathology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2017.11.023","article-title":"Current Concepts in Pathogenesis, Diagnosis, and Management of Smoking-Related Interstitial Lung Diseases","volume":"154","author":"Kumar","year":"2018","journal-title":"Chest"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.11-1062","article-title":"Combined pulmonary fibrosis and emphysema syndrome: A review","volume":"141","author":"Jankowich","year":"2012","journal-title":"Chest"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-4-6","article-title":"Centrilobular emphysema combined with pulmonary fibrosis results in improved survival","volume":"4","author":"Todd","year":"2011","journal-title":"Fibrogenesis Tissue Repair."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Checa, M., Hagood, J.S., Velazquez-Cruz, R., Ruiz, V., Garcia-De-Alba, C., Rangel-Escareno, C., Urrea, F., Becerril, C., Montano, M., and Garcia-Trejo, S. (2016). Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150383"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/CLEP.S54815","article-title":"Epidemiology of idiopathic pulmonary fibrosis","volume":"5","author":"Ley","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1378\/chest.06-1885","article-title":"Respiratory bronchiolitis-interstitial lung disease: Long-term outcome","volume":"131","author":"Portnoy","year":"2007","journal-title":"Chest"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1155\/2014\/541242","article-title":"Making an accurate diagnosis of chronic hypersensitivity pneumonitis","volume":"21","author":"Johannson","year":"2014","journal-title":"Can. Respir. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","article-title":"Hypersensitivity pneumonitis: Insights in diagnosis and pathobiology","volume":"186","author":"Selman","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1513\/AnnalsATS.201412-569OC","article-title":"The amount of avian antigen in household dust predicts the prognosis of chronic bird-related hypersensitivity pneumonitis","volume":"12","author":"Tsutsui","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1513\/pats.200906-041AL","article-title":"Hypersensitivity pneumonitis caused by fungi","volume":"7","author":"Selman","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_66","first-page":"165","article-title":"Hypersensitivity pneumonitis due to occupational inhalation of fungi-contaminated corn dust","volume":"14","author":"Cosmes","year":"2004","journal-title":"J. Investig. Allergol Clin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/10937404.2012.744288","article-title":"Respiratory health effects of large animal farming environments","volume":"15","author":"May","year":"2012","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/oem.52.9.570","article-title":"Occupational hypersensitivity pneumonitis in Japan: Data on a nationwide epidemiological study","volume":"52","author":"Yoshida","year":"1995","journal-title":"Occup. Environ. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/occmed\/kqv143","article-title":"Chemical determinants of occupational hypersensitivity pneumonitis","volume":"65","author":"Seed","year":"2015","journal-title":"Occup. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-017-0062-7","article-title":"Hypersensitivity pneumonitis: A complex lung disease","volume":"15","author":"Marinou","year":"2017","journal-title":"Clin. Mol. Allergy."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1289\/ehp.01109979","article-title":"Hypersensitivity pneumonitis from ordinary residential exposures","volume":"109","author":"Apostolakos","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"ref_72","unstructured":"Grandstaff, K. (2018, August 27). American Industrial Hygiene Association: Position Statement on Mold and Dampness in the Built Environment. [Internet]. American Industrial Hygiene Association. Available online: https:\/\/www.aiha.org\/government-affairs\/PositionStatements\/P-Mold-03-26-13.pdf."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1183\/13993003.00376-2016","article-title":"Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders","volume":"48","author":"Cramer","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2332\/allergolint.09-OA-0161","article-title":"Detection of indoor and outdoor avian antigen in management of bird-related hypersensitivity pneumonitis","volume":"59","author":"Kuramochi","year":"2010","journal-title":"Allergol. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.amjmed.2003.12.030","article-title":"The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis","volume":"116","author":"Vourlekis","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4065\/82.7.812","article-title":"Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis","volume":"82","author":"Hanak","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1148\/rg.297095707","article-title":"Hypersensitivity pneumonitis: A historical, clinical, and radiologic review","volume":"29","author":"Hirschmann","year":"2009","journal-title":"Radiographics"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.12-2685","article-title":"Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis","volume":"144","author":"Swigris","year":"2013","journal-title":"Chest"},{"key":"ref_79","first-page":"555","article-title":"Bird breeder\u2019s hypersensitivity pneumonitis: Progress studies of lung function after cessation of exposure to the provoking antigen","volume":"114","author":"Allen","year":"1976","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1164\/rccm.201608-1675PP","article-title":"Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go","volume":"196","author":"Salisbury","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Adegunsoye, A., Oldham, J.M., Fernandez Perez, E.R., Hamblin, M., Patel, N., Tener, M., Bhanot, D., Robinson, L., Bullick, S., and Chen, L. (2017). Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis. ERJ Open Res., 3.","DOI":"10.1183\/23120541.00016-2017"},{"key":"ref_82","first-page":"283","article-title":"Influence of corticosteroid treatment on the course of farmer\u2019s lung","volume":"64","author":"Monkare","year":"1983","journal-title":"Eur. J. Respir. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1164\/ajrccm\/147.4.793","article-title":"Recovery of pulmonary function in farmer\u2019s lung. A five-year follow-up study","volume":"147","author":"Kokkarinen","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis","volume":"151","author":"Morisset","year":"2017","journal-title":"Chest"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Salisbury, M.L., Gu, T., Murray, S., Gross, B.H., Chughtai, A., Sayyouh, M., Kazerooni, E.A., Myers, J.L., Lagstein, A., and Konopka, K.E. (2018). Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory. Chest, in press.","DOI":"10.1016\/j.chest.2018.08.1076"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1183\/09031936.00174910","article-title":"Significance of connective tissue disease features in idiopathic interstitial pneumonia","volume":"39","author":"Corte","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1378\/chest.10-2662","article-title":"Autoimmune-featured interstitial lung disease: A distinct entity","volume":"140","author":"Vij","year":"2011","journal-title":"Chest"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: Lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: A retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.mcp.0000170522.71497.61","article-title":"Autoimmunity and interstitial lung disease","volume":"11","author":"Jindal","year":"2005","journal-title":"Curr. Opin. Pulm Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1289\/ehp.9203","article-title":"Nested case-control study of autoimmune disease in an asbestos-exposed population","volume":"114","author":"Noonan","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"ref_94","first-page":"261","article-title":"Immunological effects of silica and asbestos","volume":"4","author":"Otsuki","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCP.0b013e3283560840","article-title":"Serologic evaluation in idiopathic interstitial pneumonias","volume":"18","author":"Papiris","year":"2012","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.rmed.2014.09.003","article-title":"Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type","volume":"108","author":"Johnson","year":"2014","journal-title":"Respir. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1378\/chest.15-1145","article-title":"Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients","volume":"149","author":"Hu","year":"2016","journal-title":"Chest"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jee, A.S., Adelstein, S., Bleasel, J., Keir, G.J., Nguyen, M., Sahhar, J., Youssef, P., and Corte, T.J. (2017). Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). J. Clin. Med., 6.","DOI":"10.3390\/jcm6050051"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/RTI.0000000000000191","article-title":"The Spectrum of Interstitial Lung Disease in Connective Tissue Disease","volume":"31","author":"Henry","year":"2016","journal-title":"J. Thorac. Imaging."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12931-014-0154-6","article-title":"Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia","volume":"15","author":"Moua","year":"2014","journal-title":"Respir. Res."},{"key":"ref_101","first-page":"B5069","article-title":"A cohort study of Danish patients with interstitial lung diseases: Burden, severity, treatment and survival","volume":"62","author":"Hyldgaard","year":"2015","journal-title":"Dan Med. J."},{"key":"ref_102","first-page":"384","article-title":"Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis","volume":"56","author":"Aggarwal","year":"2017","journal-title":"Rheumatology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.rmed.2012.07.009","article-title":"Comparison of three groups of patients with usual interstitial pneumonia","volume":"106","author":"Alhamad","year":"2012","journal-title":"Respir. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1183\/09031936.03.00105202","article-title":"BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia","volume":"22","author":"Veeraraghavan","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1378\/chest.14-3174","article-title":"Lung-Dominant Connective Tissue Disease: Clinical, Radiologic, and Histologic Features","volume":"148","author":"Omote","year":"2015","journal-title":"Chest"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","article-title":"Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis","volume":"44","author":"Tansey","year":"2004","journal-title":"Histopathology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/art.21322","article-title":"Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia","volume":"53","author":"Kocheril","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_109","first-page":"235","article-title":"Nonspecific interstitial pneumonia in collagen vascular diseases: Comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia","volume":"20","author":"Nakamura","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","article-title":"Interstitial lung disease in connective tissue disease--mechanisms and management","volume":"10","author":"Wells","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/BOR.0000000000000270","article-title":"Management of connective tissue diseases associated interstitial lung disease: A review of the published literature","volume":"28","author":"Wallace","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s10067-004-0906-7","article-title":"Experience with azathioprine in systemic sclerosis associated with interstitial lung disease","volume":"23","author":"Dheda","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"ref_113","first-page":"170","article-title":"Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: Results from the Australian Scleroderma Cohort Study","volume":"34","author":"Owen","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2016.11.007","article-title":"Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease","volume":"121","author":"Oldham","year":"2016","journal-title":"Respir. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s10067-017-3707-5","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Methotrexate and the severity of lung disease are associated to prognosis","volume":"36","author":"Mejia","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_116","first-page":"967","article-title":"Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate","volume":"22","author":"Fink","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/kel112","article-title":"Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis\/dermatomyositis","volume":"46","author":"Yamasaki","year":"2007","journal-title":"Rheumatology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13075-016-1015-0","article-title":"Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: A single-centre, retrospective analysis","volume":"18","author":"Shenoy","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.40114","article-title":"Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II","volume":"69","author":"Volkmann","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): A randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.rmed.2013.02.015","article-title":"A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis","volume":"107","author":"Parambil","year":"2013","journal-title":"Respir Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: A comprehensive review","volume":"13","author":"Mahler","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1503\/cmaj.151448","article-title":"Amyotrophic dermatomyositis","volume":"189","author":"Shenoy","year":"2017","journal-title":"CMAJ"},{"key":"ref_126","first-page":"290797","article-title":"Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis","volume":"2014","author":"Martinez","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","article-title":"Clinically amyopathic dermatomyositis","volume":"22","author":"Sato","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/16000617.00002015","article-title":"Idiopathic inflammatory myopathies and the lung","volume":"24","author":"Lega","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The Diagnosis and Treatment of Antisynthetase Syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin. Pulm. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: Expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2169\/internalmedicine.56.7956","article-title":"Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan","volume":"56","author":"Tokunaga","year":"2017","journal-title":"Intern. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1749-6632.1972.tb40243.x","article-title":"Investigative techniques in the laboratory study of coal workers\u2019 pneumoconiosis: Recent advances at the cellular level","volume":"200","author":"Harington","year":"1972","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_134","first-page":"118","article-title":"Indetification and characterization of pulmonary dust burden in pneumoconiosis","volume":"3","author":"Ehrenreich","year":"1973","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0007-0971(73)80001-4","article-title":"Asbestos-related disorders","volume":"67","author":"Parkes","year":"1973","journal-title":"Br. J. Dis. Chest"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MCP.0000000000000136","article-title":"Global perspectives of emerging occupational and environmental lung diseases","volume":"21","author":"Moitra","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ACI.0000000000000420","article-title":"Update on metal-induced occupational lung disease","volume":"18","author":"Wyman","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_138","first-page":"249","article-title":"Respiratory survey of workers in a pulp and paper mill in Powell River, British Columbia","volume":"122","author":"Wong","year":"1980","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"114S","DOI":"10.1378\/chest.79.4_Supplement.114S","article-title":"The use of pulmonary function testing and questionnaires as epidemiologic tools in the study of occupational lung disease","volume":"79","author":"Boehlecke","year":"1981","journal-title":"Chest"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MCP.0000000000000138","article-title":"Evaluation of the patient with an exposure-related disease: The occupational and environmental history","volume":"21","author":"Papali","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/rg.261055070","article-title":"Pneumoconiosis: Comparison of imaging and pathologic findings","volume":"26","author":"Chong","year":"2006","journal-title":"Radiographics"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0033-8389(22)00858-2","article-title":"Standard imaging in silicosis and coal worker\u2019s pneumoconiosis","volume":"30","author":"Stark","year":"1992","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2214\/ajr.150.2.269","article-title":"Asbestos-related pleural disease and asbestosis: A comparison of CT and chest radiography","volume":"150","author":"Friedman","year":"1988","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_144","first-page":"144","article-title":"Misdiagnosis of sarcoidosis in patients with chronic beryllium disease","volume":"20","author":"Fireman","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00408-011-9285-4","article-title":"Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada","volume":"189","author":"Ribeiro","year":"2011","journal-title":"Lung"},{"key":"ref_146","first-page":"257S","article-title":"Prevention of occupational lung disease. Task Force on Research and Education for the Prevention and Control of Respiratory Diseases","volume":"102","author":"Bates","year":"1992","journal-title":"Chest"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/oem.2006.027987","article-title":"Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers","volume":"64","author":"Cummings","year":"2007","journal-title":"Occup. Environ. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/JOM.0000000000000608","article-title":"Occupational Interstitial Lung Diseases","volume":"57","author":"Litow","year":"2015","journal-title":"J. Occup. Environ. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000192566","article-title":"Beryllium disease: A 16-year follow-up case study","volume":"25","author":"Redding","year":"1968","journal-title":"Respiration"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1378\/chest.126.6.2000","article-title":"Variable response to long-term corticosteroid therapy in chronic beryllium disease","volume":"126","author":"Sood","year":"2004","journal-title":"Chest"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bmj.1.6023.1444","article-title":"Pulmonary fibrosis associated with hypersensitivity to gold salts","volume":"1","author":"Geddes","year":"1976","journal-title":"Br. Med. J."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/rheumatology\/ker289","article-title":"Non-infectious pulmonary complications of newer biological agents for rheumatic diseases\u2014A systematic literature review","volume":"50","author":"Hadjinicolaou","year":"2011","journal-title":"Rheumatology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-induced interstitial lung disease: Mechanisms and best diagnostic approaches","volume":"13","author":"Matsuno","year":"2012","journal-title":"Respir. Res."},{"key":"ref_154","unstructured":"Camus, P. (2018, September 28). Pneumotox On Line [Internet]. Available online: https:\/\/www.pneumotox.com\/drug\/index\/."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation Pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin. Chest Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4081\/monaldi.2018.917","article-title":"Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer","volume":"88","author":"Bargagli","year":"2018","journal-title":"Monaldi Arch. Chest Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1148\/radiographics.20.5.g00se081245","article-title":"Pulmonary drug toxicity: Radiologic and pathologic manifestations","volume":"20","author":"Rossi","year":"2000","journal-title":"Radiographics"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0272-5231(03)00125-4","article-title":"Drug-induced pleural disease","volume":"25","author":"Huggins","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0272-5231(03)00138-2","article-title":"Pathologic characteristics of drug-induced lung disease","volume":"25","author":"Flieder","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21414","article-title":"Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies","volume":"104","author":"Ludwig","year":"2005","journal-title":"Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cas.12335","article-title":"Bortezomib therapy-related lung disease in Japanese patients with multiple myeloma: Incidence, mortality and clinical characterization","volume":"105","author":"Yoshizawa","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1200\/JCO.2006.10.0164","article-title":"Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma","volume":"25","author":"Zappasodi","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1634\/theoncologist.2016-0419","article-title":"Safety and Tolerability of PD-1\/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis","volume":"22","author":"Nishijima","year":"2017","journal-title":"Oncologist"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40134-017-0256-2","article-title":"Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy","volume":"5","author":"Widmann","year":"2016","journal-title":"Curr. Radiol. Rep."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1634\/theoncologist.2016-0055","article-title":"Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents","volume":"21","author":"Weber","year":"2016","journal-title":"Oncologist"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J. Immunother Cancer."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis","volume":"155","author":"Baumgartner","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"526S","DOI":"10.1378\/chest.128.5_suppl_1.526S","article-title":"Pathogenesis and natural history of usual interstitial pneumonia: The whole story or the last chapter of a long novel","volume":"128","author":"Strieter","year":"2005","journal-title":"Chest."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","article-title":"Comorbidities in idiopathic pulmonary fibrosis patients: A systematic literature review","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","article-title":"A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis","volume":"350","author":"Raghu","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial","volume":"374","author":"King","year":"2009","journal-title":"Lancet"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","article-title":"Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results","volume":"181","author":"Daniels","year":"2010","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: A parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.lfs.2007.11.003","article-title":"Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts","volume":"82","author":"Nakayama","year":"2008","journal-title":"Life Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/thoraxjnl-2015-207011","article-title":"Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: Analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis","volume":"71","author":"Nathan","year":"2016","journal-title":"Thorax"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccm.2004.05.001","article-title":"Inherited interstitial lung disease","volume":"25","author":"Garcia","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1183\/13993003.00412-2015","article-title":"The changing face of a rare disease: Lymphangioleiomyomatosis","volume":"46","author":"Harari","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2004.07.001","article-title":"Acute interstitial pneumonia","volume":"25","author":"Vourlekis","year":"2004","journal-title":"Clin. Chest Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00005382-199904000-00002","article-title":"Computed tomography and pathologic findings in fulminant forms of idiopathic interstitial pneumonia","volume":"14","author":"Akira","year":"1999","journal-title":"J. Thorac. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/12\/476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:52Z","timestamp":1760196712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/7\/12\/476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,24]]},"references-count":188,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["jcm7120476"],"URL":"https:\/\/doi.org\/10.3390\/jcm7120476","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,24]]}}}